4//SEC Filing
Bosley Katrine 4
Accession 0001179110-18-012584
CIK 0001650664other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 5:42 PM ET
Size
6.9 KB
Accession
0001179110-18-012584
Insider Transaction Report
Form 4
Bosley Katrine
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2018-11-01$27.21/sh−8,600$234,006→ 1,228,966 total - Sale
Common Stock
2018-11-01$26.03/sh−3,400$88,502→ 1,237,566 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $25.49 to $26.44. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $26.57 to $27.52. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001592469
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 5:42 PM ET
- Size
- 6.9 KB